Dietary intake of L-carnitine can promote cardiovascular diseases in humans through microbial production of trimethylamine (TMA) and its subsequent oxidation to trimethylamine N-oxide by hepatic flavin-containing monooxygenases. Although our microbiota are responsible for TMA formation from carnitine, the underpinning molecular and biochemical mechanisms remain unclear. In this study, using bioinformatics approaches, we first identified a two-component Rieske-type oxygenase/reductase (CntAB) and associated gene cluster proposed to be involved in carnitine metabolism in representative genomes of the human microbiota. CntA belongs to a group of previously uncharacterized Rieske-type proteins and has an unusual "bridging" glutamate but not the aspartate residue, which is believed to facilitate intersubunit electron transfer between the Rieske center and the catalytic mononuclear iron center. Using Acinetobacter baumannii as the model, we then demonstrate that cntAB is essential in carnitine degradation to TMA. Heterologous overexpression of cntAB enables Escherichia coli to produce TMA, confirming that these genes are sufficient in TMA formation. Site-directed mutagenesis experiments have confirmed that this unusual "bridging glutamate" residue in CntA is essential in catalysis and neither mutant (E205D, E205A) is able to produce TMA. Taken together, the data in our study reveal the molecular and biochemical mechanisms underpinning carnitine metabolism to TMA in human microbiota and assign the role of this novel group of Rieske-type proteins in microbial carnitine metabolism. methylated amine metabolism | comparative genomics | gut microbiota
Dietary intake of L-carnitine can promote cardiovascular diseases in humans through microbial production of trimethylamine (TMA) and its subsequent oxidation to trimethylamine N-oxide by hepatic flavin-containing monooxygenases. Although our microbiota are responsible for TMA formation from carnitine, the underpinning molecular and biochemical mechanisms remain unclear. In this study, using bioinformatics approaches, we first identified a two-component Rieske-type oxygenase/reductase (CntAB) and associated gene cluster proposed to be involved in carnitine metabolism in representative genomes of the human microbiota. CntA belongs to a group of previously uncharacterized Rieske-type proteins and has an unusual "bridging" glutamate but not the aspartate residue, which is believed to facilitate intersubunit electron transfer between the Rieske center and the catalytic mononuclear iron center. Using Acinetobacter baumannii as the model, we then demonstrate that cntAB is essential in carnitine degradation to TMA. Heterologous overexpression of cntAB enables Escherichia coli to produce TMA, confirming that these genes are sufficient in TMA formation. Site-directed mutagenesis experiments have confirmed that this unusual "bridging glutamate" residue in CntA is essential in catalysis and neither mutant (E205D, E205A) is able to produce TMA. Taken together, the data in our study reveal the molecular and biochemical mechanisms underpinning carnitine metabolism to TMA in human microbiota and assign the role of this novel group of Rieske-type proteins in microbial carnitine metabolism. methylated amine metabolism | comparative genomics | gut microbiota I t is increasingly clear that the human microbiota plays an essential role in our health and disease (1) (2) (3) (4) (5) . Understanding the metabolic potential of the human microbiota and its interaction with and regulation by the host and the environment holds the key to unravel the dynamic relationship between ourselves and our associated microbes (4) (5) (6) . Over the last decade, our knowledge of the human microbiota has been significantly improved thanks to technological advances, including high-throughput sequencing, development of powerful bioinformatics, and the use of germ-free animal models (7) (8) (9) (10) (11) (12) (13) . We can now not only characterize the taxonomic composition, species richness and dynamics, but combine the genetic potential encoded in human microbiota and establish the core metabolic pathways enabled by direct sequencing of the human microbiome (14, 15) .
Advances in our understanding of the microbiome functions, however, do not match the pace of taxonomic characterization of species diversity and dynamics (16) (17) (18) . Fully resolving the functional capacity encoded in the human microbiome and the dynamic effects on health and disease still remains a great challenge (11, (16) (17) (18) . Direct sequencing of the human microbiome generates datasets dominated by genes encoding pathways for central metabolism (e.g., transcriptional and translational machinery, ATP synthesis, and so forth) (14, 15) , therefore contributing little to our understanding of the variable functional capacity encoded in human microbiota between individuals (7, 8) . Furthermore, a large fraction of the genes encoded in the human microbiome remain to be functionally characterized (14, 15) . Assigning functions encoded in the human microbiome using existing databases can be problematic. For example, the Pfam protein database currently contains over 25% of protein families with no assigned functions (release 26.0) (19) .
Lack of functional characterization of key microbial functions in our microbiota is exemplified by very recent studies on cardiovascular diseases (20) (21) (22) (23) . These studies have shown that the human microbiota is responsible for the production of trimethylamine N-oxide (TMAO), which is believed to promote atherogenesis through its interaction with macrophages and lipid metabolism (20) (21) (22) (23) . TMAO is derived from the microbial metabolism of dietary quaternary amines [e.g., choline, L-carnitine, glycine betaine (GBT), and phosphatidylcholine] to trimethylamine (TMA), which is subsequently oxidized to TMAO by the host hepatic flavin monooxygenases (21, 22) . L-Carnitine (hereafter referred to as carnitine, unless otherwise specified) is considered an important nutrient for human health, playing a key role in mitochondrial fatty acid β-oxidation (24, 25) . Although carnitine can be acquired through endogenous biosynthesis, our daily demand is largely met through dietary intake from carnitine-containing food (26) . It is known that a significant proportion of dietary carnitine can be further metabolized by microbiota before absorption (20, 27) . This microbial-mediated metabolic pathway not only diverts carnitine away from the host, causing conditional carnitine deficiency in certain human populations, but promotes TMAO formation and subsequent increased risk of atherosclerosis (20, 21) . However, the underlying Significance Metabolism of L-carnitine, a compound abundant in human diet, to trimethylamine by human microbiota has been shown to promote atherosclerosis and subsequent development of heart disease. However, the underpinning molecular and biochemical mechanisms remain unknown. In this study, we reveal that a previously unidentified Rieske-type protein is responsible for carnitine transformation to trimethylamine from human microbiota. Knowledge gained in our study provides the opportunity not only to explore Rieske protein inhibitors in preventing trimethylamine formation in animal studies and clinical trials, but also for its use as a functional genetic marker to better understand human microbiota and their dynamics in our health and disease in future epidemiological studies and dietary interventions. genetic and biochemical mechanisms of carnitine-dependent TMA production in human microbiota have not been uncovered.
In this report, we describe the identification of the genetic and biochemical mechanisms for TMA production from carnitine in
Betaprobacteria Firmicutes
Oxygenase ( representative human microbiota (Gammaproteobacteria, Betaproteobacteria, Firmicutes) through a synthesis of bioinformatics, genetic, and biochemical approaches. These in vivo experiments with microbial isolates prove valuable for exploring the metabolic attributes of a particular group of microbes in carnitine metabolism guided by bioinformatics (10) . This recently identified carnitine-to-TMA enzyme is composed of an oxygenase component (CntA) and a reductase component (CntB). CntA belongs to a previously uncharacterized group of Rieske-type proteins, which are best known for ring-hydroxylation of aromatic hydrocarbons (28) . CntA has an unusual alteration of the so-called "bridging" aspartate (substituted by a glutamate residue, E205), which plays an essential role in electron transfer in catalysis in the Rieske-type protein family (29) (30) (31) (32) .
Results and Discussion
Discovery of a Carnitine Utilization Gene Cluster and Identification of a Candidate Carnitine Oxygenase (cntAB). We used the Human Microbiome Project (HMP) reference genomes (15) for mining for carnitine-degrading enzymes guided by the following hypotheses. Microbial conversion of carnitine to TMA has been studied in bacteria isolated from humans, Acinetobacter calcoaceticus (33) and Serratia marcescens (34) . It is known that the cleavage of the carbon (C)-nitrogen (N) bond of carnitine produces TMA and a four-carbon (C4) molecule, which likely enters the central tricarboxylic acid cycle in the form of malate or succinate. We therefore hypothesize that the enzyme responsible for splitting the C-N bond is clustered in the genome with enzymes responsible for the synthesis of malate and succinate because the C4 unit is further used as a carbon source in these bacteria (33, 34) . We further reasoned that a transporter is needed for microbial carnitine transport. Two types of bacterial carnitine transporters are known, a BCCT-type permease (35) and an ABC-type active transporter of the choline/betaine/carnitine family (36) . We therefore used a BLASTP algorithm to search the HMP reference genomes (754 were available as of February 2013) for genes encoding either CaiT (a BCCT type carnitine-specific antiporter) or CaiX (the carnitine-specific substrate binding protein of the ABC transporter cassette). Our BLASTP search data revealed that many gammaproteobacterial HMP genomes contain CaiT but not CaiX homologs (Table S1 ). CaiT is also found in some Betaproteobacteria and Firmicutes.
We then inspected the neighborhood of caiT for genes involved in malate or succinate metabolism and this resulted in the identification of five groups of gene clusters in 39 HMP reference genomes (Fig. 1A) , with representative isolates from various sites of the body, including skin, airway, gastrointestinal tract, and feces (Table S2) . We focused our analyses on Acinetobacter spp. because they are known to degrade carnitine to TMA (33) . A close investigation of the caiT neighborhood revealed the presence of genes likely to be involved in C4 metabolism (Fig. 1A) . These include genes coding for a malic semialdehyde dehydrogenase and a malate dehydrogenase, together channeling the C4 carbon into the central tricarboxylic acid cycle. A conserved lysR-type transcriptional regulator is present in these gene clusters. Immediately downstream of the carnitine transporter caiT is the gene encoding an acylcarnitine hydrolase, which is required for growth and hydrolysis of acylcarnitine to carnitine (37) . The functions of two other geneswhich are always present in the caiT gene cluster-are not explicit; we designate these as cntA and cntB, respectively.
Bioinformatic analyses predicted that cntB encodes a NAD (P)-dependent reductase, containing a flavin-binding domain as well as a plant-type ferredoxin [2Fe-2S] domain (Fig. 1B and Fig.  S1 ). CntA is predicted to be a member of the Rieske-type protein family, which is characterized by two histidine and two cysteine residues coordinating the [2Fe-2S] cluster (28) . Sequence analyses of CntA from HMP bacterial genomes showed conserved Rieske motif and a catalytic mononuclear iron domain (Fig. 1B) . To date, most characterized microbial Rieske-type proteins are involved in the catabolism of ring-structured aromatic compounds (Table S3) (38) . However, recent bioinfomatic and evolutional analyses suggest that Rieske-type proteins are much more diverse than previously thought (38) (39) (40) . Indeed, eukaryotic Rieske-type terminal oxygenases have also been identified [e.g., choline monooxygenase (41, 42) ], and recent studies have confirmed that Rieske-type proteins can carry out nonring hydroxylation reactions, such as oxidative demethylation (43) and oxidative carbocyclization (44) . Furthermore, many novel Riesketype proteins have been identified with no assigned function, many of which originated from newly sequenced microbial genomes (38) . Our phylogenetic analyses reveal that CntA forms a distinct group in the Rieske-type protein family, which is more closely related to the eukaryotic choline monooxygenases (Fig. 1C) . Our bioinformatic and phylogenetic analyses therefore suggest that cntAB may encode a novel enzyme that catalyses the initial step of carnitine degradation to TMA (and a C4 compound), although C-N bond cleavage by Rieske and Rieske-type enzymes has not previously been reported. The predicted pathway for carnitine metabolism to TMA is shown in Fig. 1D . (33) . This bacterium was cultivated in a defined medium with carnitine as the sole carbon source to establish whether or not it could produce TMA from carnitine. As predicted from the bioinformatics analyses, this strain could grow on carnitine as the sole carbon source (Fig. 2) . TMA production was observed in the culture supernatant supplemented with carnitine but not succinate. We then carried out marker-exchange mutagenesis to investigate if cntA/cntB genes are essential in carnitine-dependent TMA production in this strain. The results shown in Fig. 2 demonstrate that the mutants lacking either cntA or cntB, which was replaced by a gentamicinresistance gene cassette (aacC1), could no longer grow on carnitine as a sole carbon and energy source, whereas the growth on succinate was not affected. Furthermore, when the mutants were complemented with the native copy of the carnitine degradation gene cluster, their ability to grow on carnitine was restored (Fig. 2) .
Deletion of
We performed further experiments to validate the mutants by quantifying TMA production and carnitine consumption from the wild-type, the mutants, and the complemented mutants of A. baumannii ATCC19606 (Fig. 3) . Because the mutants did not grow on carnitine alone, we supplemented the medium with carnitine and succinate. As predicted, both mutants lost the ability to catalyze TMA formation from carnitine although they could grow on succinate as the sole carbon and energy source, whereas the complemented mutants restored the ability to convert carnitine to TMA. Taken together, the experiments confirmed that cntA and cntB are essential in TMA formation from carnitine.
Heterologous Expression of cntAB in Escherichia coli. To complement our experiment in vivo, we performed further experiments in vitro by heterologous expression of cntAB in Escherichia coli. We cloned these two genes (cntA, cntB) from A. baumannii into an inducible T7 promoter-specific expression system to assess whether they are sufficient to perform carnitine-dependent TMA production heterologously. Using ion-exchange chromatography, we quantified TMA formation from carnitine using the supernatant of recombinant E. coli containing either overexpressed CntA or CntB, and no TMA production was seen (Fig. 4) . However, when the two genes were coexpressed, TMA was detected from carnitine degradation using the cell-free culture extracts.
To further confirm that CntAB is sufficient for carnitinedependent TMA production, we purified CntA and CntB by affinity chromatography and successfully reconstituted the activity of carnitine-to-TMA degradation using the purified recombinant proteins (Figs. S2 and S3 ). The identity of TMA produced from carnitine oxidation by CntAB was further confirmed by gas chromatography-mass spectrometry using authentic TMA standards (Fig. S3) . Overall, our experiments demonstrate that CntA and CntB are necessary and sufficient for in vitro carnitine degradation to TMA.
The Unusual "Bridging Glutamate" Residue Is Essential in Carnitine Oxidation. Phylogenetic analyses place the CntA protein within the Rieske-type protein family (Fig. 1C) . This finding is confirmed by the presence of the highly conserved Rieske sequence motif [-CXHX [15] [16] [17] CXXH-] in CntA in HMP reference genomes (Fig. 5A) . A close investigation of the catalytic mononuclear iron center revealed the conserved two-histidine-one-carboxylate facial triad motif in these CntA proteins (45) . However, a key difference between CntA and other Rieske-type terminal oxygenases lies in the unusual substitution of the previously identified, highly conserved aspartate residue located immediately in front of the first histidine residue of the mononuclear iron center (E205) (Fig. 5A ). This glutamate residue is, however, strictly conserved in all CntA proteins identified from the 39 genomes of HMP reference strains. Although the aspartateto-glutamate substitution is conservative, it is rather unusual. X-ray crystal structures of Rieske oxygenases (e.g., naphthalene 1,2-dioxygenase, biphenyl 2,3-dioxygenase, nitrobenzene 1,2-dioxygenase) showed that the mononuclear iron and the Rieske center on the same subunit are too far (>40 Å) to allow direct electron transfer between them (46-49). The mononuclear iron centers, however, are located only ∼12 Å from the Rieske centers on the adjacent subunits of the homotrimers (46) (47) (48) (49) . It is believed that intersubunit electron transfer occurs between the ligating histidine residues which are coordinated by a so-called "bridging aspartate" residue (29) (30) (31) (32) (Fig. S4) , and substitutions of this aspartate residue to glutamate (D205E in naphthalene dioxygenase) severely diminished its catalytic activity (29) .
To gain more insight into the role of this glutamate residue in CntA, we performed site-directed mutagenesis experiments, changing this glutamate residue to either aspartate (E205D) or alanine (E205A). The mutants were purified from recombinant E. coli and activity assays were performed by quantifying NADH oxidation and TMA production. The results shown in Fig. 5B demonstrate that this glutamate residue is essential in electron transfer between the Rieske center and the mononuclear iron center because electron transfer (as determined by coupling efficiency and TMA formation) was completely abolished in the mutants. Experiments using circular dichroism and native-PAGE demonstrated that site-directed mutagenesis of CntA neither altered its secondary structure nor the oligomeric state of the protein (Fig. S5) . Our data, therefore, indicate that in CntA, a glutamate-but not aspartate-residue in this position is crucial in catalysis because neither of the mutants (E205A, E205D) could catalyze carnitine degradation to TMA (Fig. 5B) . It is interesting to note that the glutamate residue is found in at least two other enzymes of the Rieske-type protein family, dimethylproline demethylase (Stc2) (43) and GBT demethylase (GbcA) (50) , although no further data were available on the role of this residue in these proteins. Our study therefore suggests that caution needs to be taken when interpreting structure-function relationships of Rieske-type proteins using existing structures that are dominated by ring-hydroxylating oxygenases. Further X-ray structures are clearly warranted to reveal the function- structure relationships of an expanded Rieske-type protein family as revealed by bioinformatics approaches (38) (39) (40) .
Concluding Remarks
The last decade has witnessed unparalleled progress in research on the human microbiota and its complex and dynamic relationship to our health and disease. It has become increasingly evident that understanding the functional capacity encoded in the human microbiota and its variation between individuals is necessary for future personalized healthcare and targeted medication. A call for a community response to work collaboratively on the functional annotation of uncharacterized proteins was made almost a decade ago (51) , and yet proteins of unknown function in prokaryotic and eukaryotic genomes are still increasingly accumulating (18, 19) . Indeed, a large proportion of the proteins encoded in the human microbiome have not yet been functionally characterized (14, 15) , leaving a serious gap in our knowledge for complete understanding of the role of our microbiota. On the other hand, a number of specific activities of human microbiota have been discovered, with the corresponding encoding genes and biochemical mechanisms remaining unknown (reviewed in refs. 4 and 11). The key role played by human microbiota in TMA production has been known for more than a century, but we have just begun to understand the underpinning molecular and biochemical mechanisms (52) . The vital importance of the microbiota-mediated metabolic pathway for TMA formation has been convincingly highlighted by several recent studies, linking increased levels of plasma TMAO, the metabolite produced by hepatic oxidation of TMA, with elevated risk of atherosclerosis and associated acute cardiovascular diseases in humans (20) (21) (22) (23) . Demystifying the genetic and biochemical mechanisms in TMA formation can yield novel targets for future diagnosis and form baseline knowledge for personalized therapeutic strategies targeting an individual's microbiota. In this study, we report the identification of a unique Rieske protein involved in TMA formation from carnitine in human microbiota. Coincidently, Rieske proteins have been extensively studied over the last few decades and many crystal structures of Rieske proteins are readily available. Our finding now offers the opportunity to explore previously studied Rieske protein inhibitors in preventing TMA formation in animal studies and clinical trials (53) . Furthermore, knowledge gained in our study and others (52) now offers the use of functional genetic markers (e.g., cntA, cutC), in addition to the taxonomic ribosomal RNA markers, to better understand our microbiota and their dynamics in human health and disease in large-scale epidemiological and dietary intervention studies. What's more, beyond the specifics of this study, one can also envisage that the synthesis of genetic, biochemical, and bioinformatics approaches can be a valuable tool for future functional genomic studies of human microbiota, not only addressing emerging issues in microbiota-host cross-talk, but also starting to fill in the gap in our knowledge of proteins of unknown functions in human microbiome.
Materials and Methods
Bioinformatic Identification of the Carnitine Oxygenase Gene Cluster. We used sequenced microbial genomes from the HMP as the database for mining the genes involved in carnitine-to-TMA degradation. HMP references genomes were selected and analyzed through the IMG program on the Joint Genome Institute Web site (www.hmpdacc-resources.org/cgi-bin/imgm_hmp/main. cgi). Searching for homologs encoding either the carnitine-specific ABC transporter or the BCCT-type permease was carried out through the BLASTP algorithm (E value −50) using the following queries sequences CaiX (PA5388) (36) and CaiT (CAA52110) (54) . No CaiX homologs were found in the HMP reference genomes, including Serratia spp. and Acinetobacter spp. which have been previously shown to catalyze carnitine degradation to TMA (33, 34) . We found 122 close homologs (E ≤ −50) of CaiT in 91 unique genomes of Gammaproteobacteria, Betaproteobacteria, and Firmicutes, including Acinetobacter species. Because cleavage of the trimethylammonium molecule from carnitine results in the release of a C4 carbon, the neighborhood of caiT was manually inspected for genes encoding enzymes involved in the metabolism of C4 molecules, including malate, succinate, fumarate, and oxaloacetate. Sequence alignment and phylogenetic analyses were performed as described previously (55) .
Marker Exchange Mutagenesis of cntA/cntB in A. baumannii. Cultivation of A. baumannii was carried out in a defined medium supplemented with either succinate or carnitine (or both) as the sole carbon source. Targeted deletion of cntA/cntB was carried out by marker exchange mutagenesis, as described previously (56) . The mutants (ΔcntA; ΔcntB) were complemented with plasmid pKR706 by cloning the native carnitine oxygenase gene cluster into the 
